Allogene Therapeutics, Inc. (ALLO) Institutional Ownership

Institutions by Trading Activity

Ownership Statistics

217,894,737Shares Outstanding

51,069,836Shares held by institutions

$110,310,846Value of institutional holdings

72.74%Institutional ownership %

3.32%Shares Changed QoQ

158No. of institutional investors

Shares Owned by Institutions

Shares Purchased/Sold by Institutions

Ownership Summary

According to SEC filings for the period ending December 2025, Allogene Therapeutics, Inc. (NASDAQ:ALLO) is held by 158 institutional firms.

These investors collectively held 72.7% of the company's total shares outstanding in December 2025, down from 74.2% in September 2025.
On a quarter-over-quarter basis, institutional holdings shifted by 3.32%, with a year-over-year a decrease of 7.60% in the count of filers.
A review of institutional activity for Allogene Therapeutics shows 73 of 158 filers increasing their positions, while 43 reduced their stake, and 42 remained unchanged.
This class of investors increased its holdings in Allogene Therapeutics to 158.50Mn shares for the 13F-cycle ending December 2025, up by 5.10Mn shares quarter on quarter, and down 29.55Mn shares year over year.
As of December 31, 2025, PFIZER INC held Allogene Therapeutics's largest shareholding position with over 22.03Mn shares, representing 10.11% of total outstanding shares.
Among the most significant buyers of Allogene Therapeutics during December 2025 were Kalehua Capital Management LLC (2.55Mn), Candriam S.C.A. (2.31Mn), Patient Square Capital LP (1.98Mn), GOLDMAN SACHS GROUP INC (1.09Mn), PRIMECAP MANAGEMENT CO/CA/ (1.06Mn).
Leading sellers of Allogene Therapeutics stock in December 2025 included UBS Group AG (2.18Mn), CITADEL ADVISORS LLC (1.86Mn), MILLENNIUM MANAGEMENT LLC (1.55Mn), DIMENSIONAL FUND ADVISORS LP (1.13Mn), ROYAL BANK OF CANADA (1.05Mn).
The top 10 institutional holders of Allogene Therapeutics for the quarter ending December 2025 included PFIZER INC (22.03Mn), TPG GP A, LLC (18.72Mn), BlackRock, Inc. (17.68Mn), CITADEL ADVISORS LLC (12.11Mn), VANGUARD GROUP INC (9.25Mn), PRIMECAP MANAGEMENT CO/CA/ (8.14Mn), Patient Square Capital LP (4.96Mn), GEODE CAPITAL MANAGEMENT, LLC (3.93Mn), Frazier Life Sciences Management, L.P. (3.87Mn), Woodline Partners LP (3.50Mn).

158 Institutional Holders

51,069,836 Total Shares Held

Rows:

Download Data

Owner Name	Date	Shares Held	Change (QoQ)	Change (%)	Value (USD)
PFIZER INC	31 Dec, 2025	22,032,040	0	0.00%	$30,183,895.00
TPG GP A, LLC	31 Dec, 2025	18,716,306	0	0.00%	$25,641,339.00
BlackRock, Inc.	31 Dec, 2025	17,676,029	161,355	0.92%	$24,216,160.00
CITADEL ADVISORS LLC	31 Dec, 2025	12,111,420	-1,860,137	-13.31%	$16,592,646.00
VANGUARD GROUP INC	31 Dec, 2025	9,251,609	230,839	2.56%	$12,674,704.00
PRIMECAP MANAGEMENT CO/CA/	31 Dec, 2025	8,139,840	1,060,532	14.98%	$11,151,581.00
Patient Square Capital LP	31 Dec, 2025	4,963,756	1,982,360	66.49%	$6,800,346.00
GEODE CAPITAL MANAGEMENT, LLC	31 Dec, 2025	3,932,910	99,025	2.58%	$5,388,905.00
Frazier Life Sciences Management, L.P.	31 Dec, 2025	3,868,750	0	0.00%	$5,300,188.00
Woodline Partners LP	31 Dec, 2025	3,500,499	-860,109	-19.72%	$4,795,684.00
TWO SIGMA INVESTMENTS, LP	31 Dec, 2025	3,423,441	39,797	1.18%	$4,690,114.00
Wildcat Capital Management, LLC	31 Dec, 2025	2,920,787	0	0.00%	$4,001,478.00
TWO SIGMA ADVISERS, LP	31 Dec, 2025	2,890,200	108,600	3.90%	$3,959,574.00
STATE STREET CORP	31 Dec, 2025	2,761,400	6,022	0.22%	$3,783,118.00
Kalehua Capital Management LLC	31 Dec, 2025	2,546,129	2,546,129	0.00%	$3,488,197.00
Candriam S.C.A.	31 Dec, 2025	2,305,644	2,305,644	0.00%	$3,158,867.00
GOLDMAN SACHS GROUP INC	31 Dec, 2025	2,289,458	1,085,750	90.20%	$3,136,557.00
RENAISSANCE TECHNOLOGIES LLC	31 Dec, 2025	2,187,084	-706,728	-24.42%	$2,996,305.00
JANE STREET GROUP, LLC	31 Dec, 2025	2,174,683	958,910	78.87%	$2,979,316.00
Aberdeen Group plc	31 Dec, 2025	2,086,332	504,067	31.86%	$2,858,275.00

1 - 20 of 158

Research Tools